Pharma innovators have long pursued a variety of deal structures to navigate the risks associated with the drug development process. Here we explore the legal and regulatory dynamics of these creative ...
In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback